Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension

Hypertension

Volumn 45, Issue 3, 2005, Pages 326-330

  Johnson, Richard J ^a   Rodriguez Iturbe, Bernardo ^b   Nakagawa, Takahiko ^a   Kang, Duk Hee ^c   Feig, Dan I ^d   Herrera Acosta, Jaime ^e  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

^c Ewha Womans University School of Medicine   (South Korea)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; CELL COUNT; ESSENTIAL HYPERTENSION; HUMAN; HYPOTHESIS; KIDNEY INJURY; NEPHRON; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; SALT LOADING; SALT SENSITIVE HYPERTENSION; SALT TOLERANCE; SHORT SURVEY; SODIUM EXCRETION;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY DISEASES; SODIUM CHLORIDE;

EID: 14644435119     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000154784.14018.5f     Document Type: Short Survey

References (63)

1. Mahomed FA. On chronic Blight's disease and its essential symptoms. Lancet. 1879;i:399-401.
2. Dahl LK, Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975;36:692-696.
3. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983;309:1009-1015.
4. Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972; 52:584-594.
5. Elliott P, Stamler J, Nichols R, Dyer AR, Stamnler R, Kesteloot H, Marmot M; Intersalt Cooperative Research Group. Intersalt revisited: further analysis of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 1996;312:1249-1253.
6. MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M. Double-blind randomized crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982;1:351-355.
7. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996;272:676-680.
8. Karet FE, Lifton RP. Mutations contributing to human blood pressure variation. Recent Prog Horm Res. 1997;52:263-277.
9. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop GM, Farrall M, Connell J. Genome-wide mapping of human loci for essential hypertension. Lancet. 2003;361:2118-2123.
10. Province MA, Kardia SL, Ranade K, Rao DC, Thiel BA, Cooper RS, Risch N, Turner ST, Cox DR, Hunt SC, Weder AB, Boerwinkle E. A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. Am J Hypertens. 2003;16:144-147.
11. Carmelli D, Robinette D, Fabsitz R. Concordance, discordance and prevalence of hypertension in World War II male veteran twins. J Hypertens. 1994;12:323-328.
12. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution, and primitive cultures. Semin Nephrol. 2005;25:3-8.
13. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
14. Robinson SC, Brucer M. Range of normal blood pressure. A statistical and clinical study of 11 383 persons. Arch Int Med. 1939;64:409-444.
15. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension. 2004;44:398-404.
16. Lebel M, Grose JH, Blais R. Abnormal relation of extracellular fluid volume and exchangeable sodium with systemic arterial pressure in early borderline essential hypertension. Am J Cardiol. 1984;54:1267-1271.
17. Beretta-Piccoli C, Davies DL, Boddy K, Brown JJ, Cumming AMM, East BW, Fraser R, Lever AF, Padfield PL, Semple PF, Roberston JIS, Weidmann P, Williams ED. Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci. 1982;63:257-270.
18. Beretta-Piccoli C, Weidman P. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines. Miner Electrolyte Metab. 1984; 10:292-300.
19. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension. 1991;18: 67-71.
20. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988;1:335-347.
21. Murakami K, Kojima S, Kimura G, Sanai T, Yoshida K, Imanishi M, Abe H, Kawamura M, Kawano Y, Ashida T. The association between salt sensitivity of blood pressure and family history of hypertension. Clin Exp Pharmacol Physiol Suppl. 1992;20:61-63.
22. Barker DJ. The fetal origins of adult hypertension. J Hypertens Suppl. 1992;10:S39-S44.
23. Hughson M, Farris AB, Douglas-Demon R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63:2113-2122.
24. Ventura SJ, Anderson RN, Martin JA, Smith BL. Births and deaths; preliminary data for 1997. Natl Vital Stat Rep. 1998;47:1-41.
25. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004;65: 1339-1348.
26. Keller J, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348:101-118.
27. Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC. Renal outcome 25 years after donor nephrectomy. J Urol. 2001;166:2043-2047.
28. Falkner B, Hulman S, Kushner H. Effect of birth weight on blood pressure and body size in early adolescence. Hypertension. 2004;43: 203-207.
29. Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The strength of the evidence from a systematic review of the literature. J Hypertens. 1996;14:936-941.
30. Eriksson J, Forsén T, Tuomilehto J, Osmod C, Barker D. Fetal and childhood growth and hypertension in adult life. Hypertension. 2000;36: 790-794.
31. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913-923.
32. Gull W, Sutton H. On the pathology of the morbid state commonly called chronic Bright's disease with contracted kidney ("arteriocapillary fibrosis"). Med Chir Trans. 1872;55:325-371.
33. Sommers S, Relman R, Smithwick R. Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol. 1958;34: 685-715.
34. Moritz A, Oldt M. Arteriolar sclerosis in hypertensive and nonhypertensive individuals. Am J Pathol. 1937;13:679-728.
35. Tracy RE, Mercante DE, Moncada A, Berenson G. Quantitation of hypertensive nephrosclerosis on an objective rational scale of measure in adults and children. Am J Clin Pathol. 1986;85:312-318.
36. Goldblatt H. The renal origin of hypertension. Physiol Rev. 1947;27: 120-165.
37. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens. In press.
38. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004;286: F606-F616.
39. Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens. 1988;6: 763-777.
40. Black MJ, Briscoe TA, Constantinou M, Kett MM, Bertram JF. Is there an association between level of adult blood pressure and nephron number or surface area? Kidney Int. 2004;65:582-588.
41. Skov K, Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand. 2004;181:397-405.
42. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand. 2003;179:217-223.
43. Anderson WP, Kett MM, Stevenson KM, Edgley AJ, Denton KM, Fitzgerald SM. Renovascular hypertension: structural changes in the renal vasculature. Hypertension. 2000;36:648-652.
44. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber M, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens. 1996; 14:327-332.
45. Levy R, Hillman C, Stroud W, White P. Transient hypertension: It significance in terms of later development of sustained hypertension and cardiovascular renal disease. J Am Med Assoc. 1944;126:829-833.
46. Julius S. The evidence for a pathophysiologic significance of sympathetic overactivity in hypertension. Clin Exp Hypertens. 1996;18:305-321.
47. Johnson RJ, Gordon KL, Suga S, Griffin K, Bidani A. Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension. 1999;34:151-159.
48. Johnson RJ, Feig DI, Kang DH, Herrera-Acosta J. The resurrection of uric acid as a causal risk factor for hypertension. Hypertension. 2004 Nov 22; [Epub ahead of print].
49. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang D-H, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38:1101-1106.
50. Sánchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67:237-247.
51. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int. In press.
52. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, Mazzali M, Johnson RJ. Uric acid, hominoid evolution and the pathogenesis of salt-sensitivity. Hypertension. 2002;40:355-360.
53. Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004;66:1-8.
54. Pan WH, Chou J, Yen SH, Tu CA. Correlates of blood pressure differ in high and in low plasma renin groups. J Hum Hypertens. 1992;6:199-204.
55. Blumenfeld JD, Laragh JH. Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. Am J Hypertens. 1998;11:894-896.
56. Sánchez-Fructuoso AI, Blanco J, Cano M, Ortega L, Arroyo M, Fernández C, Prats D, Barrientos A. Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate. Am J Kid Dis. 2002;40:59-67.
57. Shadick NA, Kim R, Weiss S, Liang MH, Sparrow D, Hu H. Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the Normative Aging Study. J Rheumatol. 2000;27:1708-1712.
58. Quiroz Y, Pons H, Gordon KL, Rinon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition: a role for immune cells and microvascular injury. Am J Physiol Renal Physiol. 2001;281:F38-F47.
59. Tapia E, Franco M, Sanchez-Lozada LG, Soto V, Avila-Casado C, Santamaria J, Quiroz Y, Rodriguez-Iturbe B, Herrera-Acosta J. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int. 2003;63:994-1002.
60. 2+ exchanger type-1 in vascular smooth muscle. Nat Med. 2004;10:1193-1199.
61. Blaustein MP. Endogenous ouabain: role in the pathogenesis of hypertension. Kidney Int. 1996;49:1748-1753.
62. DeWardener HE. The primary role of the kidney and salt intake in the etiology of essential hypertension. Clin Sci Colch. 1990;79:193-200.
63. Johnson GI. On certain points in the anatomy and pathology of Bright's disease in the kidney. II on the influence of the minute blood-vessels upon the circulation. Med Chir Trans. 1868;51:59-76.